ACROSS Global™’s Post

Live from HLTH USA - Vindell Washington, our Chief Clinical Officer and Head of Health Equity, speaking on DEI principles to advance health equity. "At Verily, we talk about N of 1. We want to know as much as we can about each patient's journey so we can treat them as an individual." “We want to spend time with the communities we’re designing for so the outcomes lift all communities and leave no one behind. It is not only an ethical and moral thing to do, it's the right business thing to do." #HLTHUSA #HealthEquity #PrecisionHealth

Clinical trial diversity is essential for achieving true health equity. At Synthesis Health, we're tackling the key barriers that prevent underrepresented communities from participating in clinical research. 🤜 🚫 From targeted patient engagement to tailored educational materials, see how we're making a difference. Explore our latest article to find out more: https://buff.ly/3XOTEHK #ClinicalResearch #HealthEquity #DiversityAndInclusion #PatientAdvocacy #PatientCentricity #PatientEngagement #PatientExperience #PatientCentric #PatientFirst #DiversityAndInclusion #PharmaPartnerships #PatientVoice #MedComms #MedicalCommunications #HealthcareCollaboration #HealthcareCommunications #MedicalWriting

Learn the truth about clinical trial diversity and why it matters for healthcare! Understand the implications of underrepresentation and discover ways to promote inclusivity in trials in our recent blog. Let's bridge the gap in medical research – we want to hear your thoughts! #ClinicalTrials #HealthcareInclusion #Diversity

Diversity in clinical trials isn’t just a goal—it’s a necessity for advancing health outcomes. When clinical trials include people from diverse backgrounds, we gain insights that make treatments more effective and safer for all. Underrepresented communities often respond differently to treatments, meaning that inclusive trials produce more accurate, generalizable results. By broadening participation, we move closer to a healthcare system that truly serves everyone. Let’s champion diversity in clinical research to build a healthier future for all. #ClinicalTrials #HealthEquity #DiversityInResearch

Dive into the Stanford Think Tank on Diversity & #HealthEquity in Clinical Trials with our on-demand version! Join us in promoting health equity & addressing underrepresentation. #MedEd Two ways to learn: YouTube: Online Module: https://buff.ly/3J0Jwnn

Advancing health equity in clinical trials 👐 The underrepresentation of diverse groups in clinical trials remains a critical issue in the healthcare industry. At Synthesis Health, we are committed to bridging this gap through inclusive patient engagement and culturally appropriate educational materials. Read more in our latest article! 👉 Read the full post here: https://buff.ly/3XOTEHK #HealthEquity #ClinicalTrials #Diversity #Inclusion #PatientEngagement #PatientCentricity #PatientExperience #PatientCentric #PatientFirst #DiversityAndInclusion #PharmaPartnerships #PatientVoice #MedComms #MedicalCommunications #HealthcareCollaboration #HealthcareCommunications #MedicalWriting

This commentary focuses on the #socialdeterminantsofhealth and how they may be more fully integrated into engagement-capable environments. Patient partner Maggie Keresteci, MA, CHE and founding executive director of the Gattuso Centre for Social Medicine, Andrew Boozary MD MPP, discuss some of the historic and current issues facing communities and individuals that are #marginalized and describe how a large academic centre has leveraged its structures and resources to build partnerships with communities and community organizations to address these challenges. Healthcare Excellence Canada https://lnkd.in/gWejDQxV

What are the business and legal issues impacting Health Care & Life Sciences in 2024 and beyond? Foley's Top Trends report examines the significant factors reshaping companies across the sector.

What are the business and legal issues impacting Health Care & Life Sciences in 2024 and beyond? Foley's Top Trends report examines the significant factors reshaping companies across the sector.

What are the business and legal issues impacting Health Care & Life Sciences in 2024 and beyond? Foley's Top Trends report examines the significant factors reshaping companies across the sector.